Giant left atrium and mitral valve disease: early and late results of surgical treatment in 40 cases.
Forty consecutive patients undergoing mitral valve replacement with a giant left atrium, form the basis of this report. Two groups could be identified: (a) isolated giant left atrium (11 cases); (b) combined left and right atrial enlargement (29 cases). Tricuspid regurgitation was only detected in the latter group. The early hospital mortality was 20% and was related to the pulmonary arterial systolic pressure. A giant left atrium increased the operative mortality from 7% to 20% among patients submitted to mitral valve replacement in our unit (p less than 0.05).
D000293:Adolescent; D000328:Adult; D000368:Aged; D006332:Cardiomegaly / Q000150:complications*; D002315:Cardiopulmonary Bypass; D005260:Female; D005500:Follow-Up Studies; D006325:Heart Atria; D006350:Heart Valve Prosthesis / Q000401:mortality; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve; D008944:Mitral Valve Insufficiency / Q000150:complications / Q000503:physiopathology / Q000601:surgery*; D011183:Postoperative Complications; D014262:Tricuspid Valve Insufficiency / Q000150:complications